<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2989</number>
    <updateDate>2020-02-10T17:06:40Z</updateDate>
    <updateDateIncludingText>2020-02-10T17:06:40Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2008-05-07</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2008-05-07T19:38:57Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>National Neurotechnology Initiative Act</title>
        <congress>110</congress>
        <number>5989</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2008-05-08</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2008-05-07</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2008-05-07</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S3899-3900)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-05-07</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>M001111</bioguideId>
        <fullName>Sen. Murray, Patty [D-WA]</fullName>
        <firstName>Patty</firstName>
        <lastName>Murray</lastName>
        <party>D</party>
        <state>WA</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000407</bioguideId>
        <fullName>Sen. Domenici, Pete V. [R-NM]</fullName>
        <firstName>PETE</firstName>
        <lastName>DOMENICI</lastName>
        <party>R</party>
        <state>NM</state>
        <middleName>VICHI</middleName>
        <sponsorshipDate>2008-05-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Artificial intelligence</name>
        </item>
        <item>
          <name>Biomedical engineering</name>
        </item>
        <item>
          <name>Brain</name>
        </item>
        <item>
          <name>Brain diseases</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Commercialization</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Economic impact statements</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Executive reorganization</name>
        </item>
        <item>
          <name>Federal advisory bodies</name>
        </item>
        <item>
          <name>Federal aid to research</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Governmental investigations</name>
        </item>
        <item>
          <name>Medical ethics</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Medical technology</name>
        </item>
        <item>
          <name>National Institutes of Health (NIH)</name>
        </item>
        <item>
          <name>Nervous system diseases</name>
        </item>
        <item>
          <name>Neurology</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Psychiatry</name>
        </item>
        <item>
          <name>Research centers</name>
        </item>
        <item>
          <name>Research ethics</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Small business</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2008-05-07</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2008-08-21T14:41:55Z</updateDate>
        <text><![CDATA[ <p>National Neurotechnology Initiative Act - Defines &quot;neurotechnology&quot; to mean the science and technology that allows an individual to analyze, understand, treat, and heal the brain and nervous system.</p><p>Requires the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, under which the Secretary shall: (1) establish goals, priorities, and metrics for evaluation for federal neurotechnology research, development, and commercialization; (2) increase the investment in federal research, development, and translational programs in neurotechnology to achieve such goals; and (3) increase interagency coordination.</p><p>Requires the Secretary to establish the National Neurotechnology Coordination Office and the National Neurotechnology Advisory Council.</p><p>Requires the Director of the National Institutes of Health (NIH) to develop the Blueprint for Neuroscience Research to: (1) identify pervasive challenges in neuroscience and any technological barriers to solving such challenges; and (2) support the development of new tools, training opportunities, and other resources to assist neuroscientists in basic and clinical research. </p><p>Directs the Commissioner of Food and Drugs to require the Directors of the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health to improve the timelines of the review process for neurology and psychiatry.</p><p>Requires the Director of the National Neurotechnology Coordination Office to establish the American Neurotechnology Study Center.</p>]]></text>
      </summary>
    </summaries>
    <title>National Neurotechnology Initiative Act</title>
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>National Neurotechnology Initiative Act</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>National Neurotechnology Initiative Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to direct the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, and for other purposes.</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2008-05-07T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110s2989is/xml/BILLS-110s2989is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2008-05-07</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
